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Extensive astrocyte 
synchronization advances neuronal 
coupling in slow wave activity in 
vivo
Zsolt Szabó  1, László Héja  1, Gergely Szalay2, Orsolya Kékesi1, András Füredi3,6, Kornélia 
Szebényi3,6, Árpád Dobolyi4, Tamás I. Orbán3, Orsolya Kolacsek3, Tamás Tompa2, Zsombor 
Miskolczy5, László Biczók  5, Balázs Rózsa2, Balázs Sarkadi3 & Julianna Kardos  1
Slow wave activity (SWA) is a characteristic brain oscillation in sleep and quiet wakefulness. Although 
the cell types contributing to SWA genesis are not yet identified, the principal role of neurons in the 
emergence of this essential cognitive mechanism has not been questioned. To address the possibility 
of astrocytic involvement in SWA, we used a transgenic rat line expressing a calcium sensitive 
fluorescent protein in both astrocytes and interneurons and simultaneously imaged astrocytic and 
neuronal activity in vivo. Here we demonstrate, for the first time, that the astrocyte network display 
synchronized recurrent activity in vivo coupled to UP states measured by field recording and neuronal 
calcium imaging. Furthermore, we present evidence that extensive synchronization of the astrocytic 
network precedes the spatial build-up of neuronal synchronization. The earlier extensive recruitment 
of astrocytes in the synchronized activity is reinforced by the observation that neurons surrounded by 
active astrocytes are more likely to join SWA, suggesting causality. Further supporting this notion, we 
demonstrate that blockade of astrocytic gap junctional communication or inhibition of astrocytic Ca2+ 
transients reduces the ratio of both astrocytes and neurons involved in SWA. These in vivo findings 
conclusively suggest a causal role of the astrocytic syncytium in SWA generation.
Increasing body of evidence substantiating the impact of astrocytes on neuronal activity prompted a paradigm 
shift from the neurocentric philosophy of nervous system function. Accordingly, astrocytes are increasingly rec-
ognized as major players in the modulation of neuronal function under both physiological1–3 and pathophysiolog-
ical conditions4–7. Beyond the local astroglial control over synaptic activity8–12, however, little is known about the 
role of astrocytic networks in modulating large-scale neuronal ensembles. Exploration of the role of large-scale 
astrocytic networks in information processing and cognition still lags behind its neuronal counterpart13, 14. We 
conceived that fundamental properties of networking astrocytes may underlie physiological network-network 
interaction between astrocytes and neurons. Astrocytes are capable of 1) detecting neuronal activity, 2) respond-
ing to this activity by raising local Ca2+ transients, 3) propagating the local changes over extended spatial scales 
by Ca2+ waves traveling through the directly and densely interconnected astrocytic syncytium and 4) modulating 
neuronal activity at multiple locations by releasing gliotransmitters and other neuromodulatory substances or 
regulating ionic homeostasis15. Thus, astrocytes are ideally positioned to induce or contribute to synchroniza-
tion of large-scale neuronal networks. Along this line, we have previously demonstrated that the astrocytic and 
1Institute of Organic Chemistry, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Magyar 
tudósok körútja 2, 1117, Budapest, Hungary. 2Institute of Experimental Medicine, Hungarian Academy of Sciences, 
Szigony 43, 1083, Budapest, Hungary. 3Institute of Enzymology, Research Centre for Natural Sciences, Hungarian 
Academy of Sciences, Magyar tudósok körútja 2, 1117, Budapest, Hungary. 4MTA-ELTE Laboratory of Molecular 
and Systems Neurobiology, Department of Physiology and Neurobiology, Eötvös Loránd University, Pázmány Péter 
sétány 1C, 1117, Budapest, Hungary. 5Institute of Materials and Environmental Chemistry, Research Centre for 
Natural Sciences, Hungarian Academy of Sciences, Magyar tudósok körútja 2, 1117, Budapest, Hungary. 6Institute 
of Cancer Research, Medical University Wien, Borschkegasse 8a, 1090, Wien, Austria. Zsolt Szabó and László Héja 
contributed equally to this work. Correspondence and requests for materials should be addressed to L.H. (email: 
heja.laszlo@ttk.mta.hu)
Received: 12 January 2017
Accepted: 26 May 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 7: 6018  | DOI:10.1038/s41598-017-06073-7
neuronal networks are co-synchronized and the astrocytic network activation dynamics did significantly contrib-
ute to the emergent neuronal synchronization during seizure-like events16. We have also shown that disruption 
of long-range astrocytic coupling by gap junction blockade prevented the appearance of seizure-like events or 
significantly reduced their magnitude16. In the present study, we explored whether astrocytic networks may also 
play a role in vivo in the generation of a physiological synchronous neuronal activity, the slow-wave oscillations.
Slow-wave sleep is the deepest phase of non-rapid eye movement sleep, characterized by slow/delta wave 
oscillations at 0.5–2 Hz17, 18. The neuronal network-level oscillations observed by EEG or local field potential 
(LFP) measurements correspond to the fluctuations of neuronal membrane potentials between more silent, 
hyperpolarized DOWN states and more active, depolarized UP states, during which neuronal firing probability 
is highly increased. Although it is widely recognized that the slow wave activity (SWA) plays a crucial role in 
many important physiological functions, especially memory consolidation19, it is largely unknown what mech-
anisms are responsible for the emerging neuronal synchronization and its propagation from the cortex to var-
ious areas. Despite the early observations back in the 1960s showing that the active cell types during sleep are 
non-pyramidal20, even the identity of the cells specifically activated in SWA is still mainly unclear.
Here we explored whether astrocytic and neuronal networks are co-activated during SWA by using a recently 
developed transgenic rat line stably expressing the Ca2+-sensitive fluorescent protein GCaMP221 in astrocytes and 
interneurons. We have observed that not only neurons, but also astrocytes show concurrent network-level activity 
during UP states. Importantly, extensive (>70%) involvement of the astrocytic network appeared earlier than 
that of the neuronal network, suggesting causality. Moreover, blockade of gap junctions reduced the magnitude 
of slow waves and specific blockade of either astrocytic Cx43 connexins or astrocytic Ca2+ signalling decreased 
the number of both neurons and astrocytes activated during UP states. Conclusively, these observations strongly 
support the contribution of astrocytes to SWA generation and substantiate the role of astrocytic activation in 
coordinating synchronized network activity.
Results
GCaMP2 is expressed in astrocytes and interneurons. Physiological activation of astrocytes in vivo 
can be followed by genetically encoded Ca2+ sensors22, 23. To explore the potential activation and interference of 
networking astrocytes with the neuronal activity during slow-wave sleep, we used a novel stable transgenic rat line 
expressing the Ca2+-sensitive fluorescent protein GCaMP2 under the control of a non-specific, synthetic CAG 
promoter21, 24. The cell types expressing GCaMP2 were identified by immunostaining and electrophysiological 
characterization.
GCaMP2 immunoreactivity was found in all regions of organotypic cortical and hippocampal slices pre-
pared from the transgenic rats (Fig. 1A, Supplementary Fig. 1). Importantly, many of the GCaMP2-positive 
cells were also stained by the astrocyte-specific marker anti-GFAP (Fig. 1A, Supplementary Fig. 1A), suggesting 
that GCaMP2 is expressed in astrocytes. After 10 days in culture (DIV10) 37.5% of total DAPI-labeled cells 
were expressing both GCaMP2 and GFAP in layer 2 (Pearson’s coefficient of colocalization was calculated to 
be 0.581). Since astrogliosis is known to occur in organotypic slices and GFAP overexpression is a hallmark of 
reactive astrocytes25, we explored whether GCaMP2 is expressed in reactive or non-reactive astrocytes. In line 
with increasing astrogliosis, we found that GFAP expression has been increasing during slice culturing (Fig. 1B). 
However, GCaMP2 expression level did not increase, instead slightly decreased over time (Fig. 1B), validating 
that GCaMP2 is expressed in non-reactive astrocytes. Moreover, we investigated whether GCaMP2 is expressed 
in microglia, another glial class that is activated in organotypic slice cultures. Anti-Iba1, a specific marker of 
microglia, however, did not colocalize with GCaMP2 (Supplementary Fig. 1A).
To the contrary, GCaMP2 immunostaining was found to be colocalized in both the cortex and the hippocam-
pus with anti-GAD67, a specific marker of GABAergic interneurons (Fig. 1A, Supplementary Fig. 1A). DIV10) 
16.7% of total DAPI-labeled cells were expressing both GCaMP2 and GAD67 (Pearson’s coefficient of colocal-
ization was calculated to be 0.470). In addition, we also observed partial colocalization of the neuronal marker 
anti-NeuN with GCaMP2-positive cells, especially in the str. radiatum of the hippocampus (Supplementary 
Fig. 1A), where majority of the interneurons reside26. Importantly, however, both GCaMP2-immunoreactivity 
(Supplementary Fig. 1A), as well as native GCaMP2 expression was lacking in the str. pyramidale (Supplementary 
Fig. 1B), suggesting that GCaMP2 is not expressed in pyramidal cells.
To validate the immunohistochemical data on the expression of GCaMP2 in both neurons and astrocytes, 
we investigated electrophysiological characteristics of GCaMP2 expressing cells in organotypic cortical (n = 37 
cells) and hippocampal (n = 65 cells) slices prepared from P6 rats by performing whole-cell recordings. Cells 
were patch clamped and the presence or absence of voltage-dependent currents was investigated in voltage clamp 
mode by depolarizing current pulses. The I-V curve of 81% of GCaMP2 expressing cells (n = 30) was found to 
be linear (Fig. 1B) with low input resistance (53.1 ± 8.0 MΩ), suggesting that they were astrocytes27, 28. Average 
membrane potential of astrocytes was −78.1 ± 1.9 mV in line with previous studies27, 29, 30 and injection of positive 
currents did not induce action potentials in these cells (Fig. 1C). The other subset of GCaMP2 expressing cells 
(n = 7) displayed markedly different I–V curve (Fig. 1C), with clear voltage-dependent currents and significantly 
higher input resistance (268.0 ± 69.6 MΩ). Furthermore, in contrast to cells characterized as astrocytes, these cells 
were able to generate action potentials in response to current injection in current clamp mode (Fig. 1C). Average 
membrane potential of these cells was found to be −76.4 ± 4.0 mV.
Data from organotypic hippocampal slices showed very similar results. 75% of cells (n = 49) were found to be 
astrocytes with average membrane potential of −73.4 ± 1.9 mV and average input resistance of 85.2 ± 15.3 MΩ. 
The other 25% of cells (n = 16) were classified as neurons with average membrane potential of −78.7 ± 3.6 mV 
and average input resistance of 307.7 ± 42.4 MΩ.
It is to note that the input resistance of astrocytes we measured here is slightly higher than classically reported 
in acute slices from adult animals29, 31. This divergence is reasonably attributed to the age of the animals (P6) 
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used for preparing organotypic cultures. Expression of Kir4.1 channels has been shown to be increasing during 
development30, resulting in lower input resistance. Furthermore, relative distribution of low-resistance passive 
astrocytes and higher-resistance variably rectifying astrocytes is also drastically changing during the first 2–3 
weeks of development in favor of lower resistance in adult animals29, 32. Notably, the low (<100 MΩ) astrocytic 
input resistance complements immunohistochemical characterization and further confirms that GCaMP2 is not 
expressed in reactive astroyctes, since their input resistance is substantially higher33.
In summary, in vitro data from immunohistochemical and electrophysiological studies confirmed that our 
transgenic rat line expresses GCaMP2 in both astrocytes and interneurons, two populations of neural cells that 
both may play a key role in generating synchronous brain activity.
Figure 1. GCaMP2 is expressed in astrocytes and interneurons (A) Astrocytic and neuronal localization of 
GCaMP2 protein in organotypic cortical slices as shown by colocalization with the astrocyte-specific GFAP and 
interneuron-specific GAD-67 markers. Cells showing colocalization are marked by arrows. Scale bars: 50 μm. 
(B) Changes in GCaMP2 and GFAP expression as measured by average intensity within cell ROIs (n = 22–34 
cells) in organotypic cortical slices as a function of days in culture (DIV). (C,D) Representative traces (top), 
I/V plot (middle) and action potential generating ability (bottom) of whole-cell patched GCaMP2 expressing 
astrocytes (C, n = 30) and neurons (D, n = 7) in organotypic cortical slices.
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In vitro characterization of GCaMP2 response to pharmacological manipulation. To evaluate the 
potential of GCaMP2 expressing transgenic rats to monitor changes in intracellular Ca2+ concentration, organo-
typic cortical and hippocampal slices were subjected to pharmacological tools inducing [Ca2+] increase in both 
neurons and astrocytes (Fig. 2, Supplementary Fig. 2, Supplementary Information Movie 1–3). Bath application 
of ATP triggered a significant increase in GCaMP2 fluorescence in all cells, which gradually declined thereafter 
(Fig. 2A). 100 µM glutamate (Glu) induced repetitive Ca2+ transients (Fig. 2B) in both soma and dendrites (see 
also Supplementary Information Movie 2). Finally, application of the Ca2+ ionophore ionomycin resulted in pro-
gressive increase in GCaMP2 fluorescence corresponding to accumulation of intracellular Ca2+. The fluorescence 
increase could be reversed by application of the Ca2+ chelator ethylene glycol tetraacetic acid (EGTA) (Fig. 2C).
Figure 2. Pharmacological characterization of GCaMP2 response in organotypic cortical slices in vitro. (A–C) 
Representative fluorescent intensity changes of CAG-GCaMP2 in response to 1 mM ATP (A, n = 3), 100 μM 
Glu (B, n = 3) and 10 μM ionomycin without and with 10 mM Ca2+ chelating ethylene glycol tetraacetic acid 
(EGTA) (C, n = 3). Scale bars: 50 μm.
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Together, these results indicate that Ca2+ signalling is unimpeded in GCaMP2-expressing transgenic animals.
Both astrocytes and neurons are activated during SWA in vivo. In order to simultaneously meas-
ure the activity of neuronal and astroglial networks in vivo, rats expressing GCaMP2 were anesthetized with 
100 mg/kg ketamine and 5 mg/kg xylazine, a well-known model of slow-wave sleep that reproduces major char-
acteristics of SWA34. Discrimination of astrocytic and neuronal expression of GCaMP2 was done by admin-
istration of sulforhodamine-101 (SR101) either i.v. (10 mM, 100 μl) or onto the surface of the cerebral cortex 
during the cranial window preparation (200 μM, 2 μl). Cells showing both GCaMP2 fluorescence and SR101 
labeling were identified as astrocytes, while cells displaying only GCaMP2 fluorescence were classified as neurons 
(Fig. 3A, Supplementary Fig. 3). Fluorescence intensity of neurons and astrocytes (3 to 65 cells per field of view 
of which 67 ± 8% were astrocytes) were continuously monitored in layer 2 of the V1 cortical area. Interestingly, 
we observed that during SWA, not only neurons, but also astrocytes displayed spontaneous recurrent fluorescent 
peaks corresponding to intracellular Ca2+ transients with approximately 1 Hz frequency (Fig. 3B,C). To explore 
whether these recurrent Ca2+ transients correspond to an increased activity during UP states of slow-wave sleep, 
we performed parallel field potential recordings in the same area. Both neuronal and astroglial Ca2+ transients 
coincided with positive half-waves of the LFP signal (Fig. 3B). Spectral analysis of the LFP signal showed that 
both spindle (8–14 Hz) and gamma (30–70 Hz) range activities were also time-locked to the positive half-waves 
(Fig. 3D–G). Since gamma range activity is known to be coupled to UP states34, these results confirm that the pos-
itive half-waves represent the UP states, therefore increased astrocytic activity appears in parallel with enhanced 
neuronal firing. Noteworthy, neither neuronal nor astroglial Ca2+ transients were observed when the animals 
were anesthetized with fentanyl (0.05 mg/kg, n = 5) or lower dose of ketamine/xylazine (50 and 5 mg/kg, respec-
tively, n = 4).
In conclusion, the astrocytic network has been found to be participating in the SWA simultaneously with 
neuronal firing in UP states.
Extensive synchronization emerges in the astrocytic network earlier than in the neuronal 
one. To explore the potential interaction between neuronal and astroglial network activities and the role 
astrocytic activation may play in the SWA, we analyzed the temporal and spatial profiles of neuronal and 
astrocytic Ca2+ transients during the anesthesia from 15 to 100 min following ketamine/xylazine administra-
tion (Figs 4 and 5). In the temporal domain no difference was observed between the astrocytic and neuronal 
signals. Cross-correlation of fluorescent traces showed no time lag between the neuron-neuron (n = 1742) or 
astrocyte-astrocyte (n = 7514) pairs (Figs 4C and 5B) and also no temporal delay was measured between the neu-
ronal and astrocytic transients (n = 1693, Figs 4C and 5B). Therefore, neuronal and astrocytic calcium transients 
are fully synchronized in the temporal domain, neither one precedes the other. It is to note, however, that short 
delays in the low millisecond range may exist that is beyond the temporal resolution (typically ~30 ms) of our 
imaging setup. In addition, no significant difference was found between the frequency of neuronal and astrocytic 
peaks, albeit they slightly increased within experiments starting from the onset of ketamine/xylazine application 
and were also moderately variable between different animals (Fig. 5B). Similarly, amplitudes of neuronal and 
astrocytic peaks were also indistinguishable (Fig. 5B).
In contrast to the temporal characteristics, the spatial extensions of the astrocytic and neuronal transients 
were clearly distinguishable: it was found that significantly more astrocytes than neurons were active in the early 
phase of SWA (Fig. 4A,B). To quantify this difference, we calculated the ratio of neurons and astrocytes showing 
recurrent activity. The number of active cells was divided by the total number of GCaMP2-expressing astrocytes 
or neurons in the field of view, giving the astrocytic and neuronal spatial consistency ratios (Figs 4B and 5A). 
Neuronal spatial consistency increased over time that was showed by the increasing ratio of cells joining the 
synchronized activity (Fig. 5A). After approximately 80 min of anesthesia, virtually all neurons were involved in 
the synchronized activity in line with previous studies showing that after 60 min, ~90% of neurons participated 
in synchronous firing35. Importantly, however, the ratio of astrocytes involved in the synchronous activity was 
significantly higher (p < 0.001) than that of neurons in the first 30 min of anesthesia (Figs 4A,B and 5A), arising 
the possibility that the astrocyte network may play a critical role in the emergence of slow neuronal oscillations 
during sleep. Astrocytic and neuronal spatial consistency was also found to be distinct at the late stage of anes-
thesia. While the neuronal network remained fully involved in the synchronized activity, astrocytic involvement 
declined at this stage, further suggesting that the activity of the astrocytic network may be independent from the 
neuronal one.
The above described divergence between the spatial consistency of neuronal and astrocytic networks was 
confirmed by data from 5 different rats (P21-P83, Fig. 5A). Collective data showed that spatial consistency was 
significantly higher in the astrocytic network than in the neuronal one (83.2 ± 3.2% vs. 50.6 ± 4.6%, p < 0.001) in 
the first 30 min of anesthesia. This marked difference between the spatial scale of involvement of astrocytes and 
neurons in the SWA may suggest that astrocytes play an important role in the build-up of synchronized activity.
Noteworthy, although SR101 is a widely used marker of astrocytes in vivo, to exclude the misidentification of 
astrocytes due to potential neuronal uptake of SR101, a transgenic rat expressing the red-fluorescent RGECO pro-
tein specifically in astrocytes under the control of a GFAP promoter was also studied (Supplementary Fig. 2). The 
percentage of active astrocytes and neurons as well as the amplitude and frequency of the associated Ca2+ tran-
sients from this rat (empty symbols in Fig. 5A,B) are in accordance with the data from the SR101-labeled animals.
The higher ratio of astrocytes involved in the early phase of SWA does not necessarily constitute causal rela-
tionship between astrocytic and neuronal activity. The emergence of wide-scale neuronal involvement in the 
synchronized activity might also be attributable to independent factors. To investigate whether astrocytic network 
activation does trigger the incorporation of additional neurons into SWA we further investigated the spatial cor-
relation of the activity of the two networks. We found that the number of active astrocytes (showing SWA-related 
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Figure 3. Both astrocytes and neurons are active during UP states in vivo in the rat primary visual cortex V1. 
(A) Top: Expression of GCaMP2 (green), labeling of astrocytes with SR101 (red). Both neurons (some marked 
by arrows) and astrocytes (some marked by arrowheads) express GCaMP2. Bottom: Zoomed-in image of the 
area marked by white rectangle at the top row. Scale bars: 100 µm. (B) 10-sec segments of ∆F/F0 fluorescent 
intensity traces of all identified astrocytes (n = 21) and neurons (n = 13) in the imaged area. (C) Simultaneous 
recording of local field potential (LFP, filtered at 0.1–4 Hz) and corresponding Ca2+ transients in a neuron 
(black) and an astrocyte (red) during SWA under ketamine-xylazine anesthesia. (D–G) Characteristic LFP 
activity in the slow wave (0.1–4 Hz), spindle (8–14 Hz) and gamma (30–70 Hz) frequency ranges as filtered LFP 
recordings (top) and their wavelet transformations (bottom). All data were recorded from the V1 area of a P76 
rat (n = 15 imaging session, 60 s each).
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activity) in the vicinity of a neuron significantly influences whether the given neuron is getting involved in SWA 
(Fig. 5C). Only 46% of neurons not having an active astrocyte within 100 µm were found to be active. In contrast, 
72% of neurons having at least four active astrocyte neighbours within the same radius showed SWA-related 
activity. This correlation suggests that the activity of neurons and astrocytes are correlated, but it does not contain 
information about which cell is activating the other. The higher number of active astrocytes in the vicinity of an 
active neuron may also reflect the activation of astrocytes by nearby active neurons. However, in this case, astro-
cytic activity should also be increased when the number of active surrounding neurons is increased. However, 
this correlation was opposed by the experimental data, showing that the number of nearby active neurons does 
not affect the activity of astrocytes (Fig. 5C). Noteworthy, the activity of neurons or astrocytes were found to be 
correlating to the number of nearby neurons or astrocytes, respectively, confirming the ability of intra-network 
synchronization in both cell populations (Fig. 5C).
Inhibition of astrocytic synchronization suppresses slow wave activity. Since astrocytic gap junc-
tions are far more abundant than neuronal ones36 and through them the astrocytic syncytium can be quickly syn-
chronized in large areas, the earlier extensive synchronization of the astrocytic network suggested the role of gap 
junctions in the build-up of SWA. To explore this possibility, we blocked gap junctional communication, thereby 
inhibiting the spreading of Ca2+ transients throughout the astrocytic syncytium. Neuronal and astrocytic Ca2+ 
dynamics as well as LFP in layer 2 of the V1 area were monitored for 60 min during anesthesia, followed by i.p. 
application of the gap junction inhibitor carbenoxolone (CBX) at 100 mg/kg concentration that was demonstrated 
to be effective in blocking gap junctions in vivo37, 38. We observed that the ratio of astrocytes showing periodic 
Ca2+ transients significantly decreased after CBX application (Fig. 6A). In average, 47.4 ± 3.6% of astrocytes were 
active during the control period compared to 9.1 ± 3.2% after CBX treatment (p < 0.001). In parallel, the ratio 
of neurons involved in the slow wave-related Ca2+ activity was also significantly decreased (from 34.7 ± 6.1% to 
9.0 ± 3.3%, p = 0.001), suggesting that astrocytic synchronization plays a causal role in the generation and/or 
maintenance of neuronal synchrony.
Figure 4. Astrocytes are more broadly involved in SWA than neurons in the early stage of ketamine/xylazine 
anesthesia. (A–C) Changes in the involvement of neurons and astrocytes in the network activity during 
SWA under ketamine-xylazine anesthesia after 21 min, 29 min and 100 min from the onset of anesthesia. (A) 
Fluorescent intensity changes detected in neurons and SR101-identified astrocytes. Individual Ca2+ traces 
(gray) and their averages in neurons (black) and astrocytes (red) are shown on 5-sec segments of the imaging 
sessions at each time point. (B) The ratio of neurons (black) and astrocytes (red) showing repetitive Ca2+ 
transients in percentage of all astrocytes or neurons, respectively, in the field of view in this particular imaging 
session. (C) Cross-correlation of neuron/neuron (black), astrocyte/astrocyte (red) and astrocytes/neuron (blue) 
pairs of active cells (n = 12–420 cell pairs). All data were recorded from the V1 area of a P78 rat.
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Importantly, the inhibitory effect of CBX was also evident on the simultaneously measured LFP. In parallel 
with the decreasing ratio of Ca2+ spiking neurons, the amplitude of the positive deflections of the LFP signal 
was significantly decreased (Fig. 6B, 0.512 ± 0.002 mV vs. 0.416 ± 0.002 mV during the control period and CBX 
application, respectively, p < 0.001), confirming that decreasing number of neurons took part in the synchronized 
activity after CBX application.
Although CBX is a widely used inhibitor of gap junctional communication, and, to our knowledge, the only 
gap junction inhibitor that can penetrate the blood-brain barrier, it is not specific to astrocytic gap junctions, but 
it also acts on neuronal connexins39, 40 and cardiac gap junctions41. Since inhibition of neuronal Cx36 may also 
result in reduced synchronization42, we opted to specifically block the astrocytic Cx43 isoform with a specific anti-
body against its gating peptide segment43, which has previously been demonstrated to inhibit Cx43 function16, 39. 
The Cx43 antibody (0.75 mg/ml, 10 μl) was applied to the cortical surface 24 hours before the experiment to 
ensure antibody penetration into layer 2. Although SWA-related Ca2+ transients could still be observed in the 
presence of the Cx43 antibody, the ratio of both neurons and astrocytes involved in the rhythmic activity was 
significantly reduced (Fig. 7). Following ketamine/xylazine administration, the increase in the number of neurons 
and astrocytes participating in SWA was not observed. Instead, the ratio of active cells slowly decreased over time. 
Only 26.2 ± 1.8% of neurons and 14.3 ± 1.7% of astrocytes showed SWA-related activity at 20 to 60 min of anes-
thesia in the presence of Cx43 antibody compared to 63.6 ± 5.2% and 87.1 ± 3.0% in control conditions (p < 0.001 
for both neurons and astrocytes). The results clearly demonstrate that specific blockade of astrocytic gap junctions 
inhibited SWA-related activity to extend over larger cell populations.
To further explore the causal relationship between astrocytic activity and SWA, we used thapsigargin, a 
specific inhibitor of endoplasmic reticulum Ca2+-ATPases, that prevents refilling of internal Ca2+ stores and 
Figure 5. Extensive synchronized astrocytic activity contributes to the emergent neuronal synchronization in 
the early stage of ketamine/xylazine anesthesia. (A) The ratio of astrocytes (red) and neurons (black) showing 
repetitive, UP state-related Ca2+ transients in percentage of all astrocytes or neurons, respectively, in the field 
of view from 5 different (P21-P83) animals (left) and their averages at 5-minute intervals (mean ± SD) (right). 
Asterisks show significant differences between astrocytes and neurons (p < 0.001). (B) Frequency and amplitude 
of detected UP state-related Ca2+ transients. (C) Effect of the number of surrounding (d < 100 μm) active cells 
on the ratio of astrocytes (red) and neurons (black) showing repetitive, UP state-related Ca2+ transients in 
percentage of all astrocytes or neurons, respectively, having the same number (0) or same minimum number 
(1+, 2+, etc.) of adjacent cells. Percentage data are calculated from n = 5 (P21–P83) animals. Red markers 
represent astroglia, black markers represent neurons. Different symbols represent data from different animals. 
Astrocytes were identified by SR101 loading (solid symbols) or by astrocyte-specific expression of the red-
fluorescence RGECO protein under the control of a GFAP promoter (empty symbols). Ketamin/xylazine was 
applied at t = 0.
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was demonstrated to specifically inhibit astrocytic Ca2+ transients in vivo, while leaving neuronal Ca2+ signals 
unaffected44. Thapsigargin (0.5 mM, 10 μl) was applied to the cortical surface 30 min before the experiment. 
Thapsigargin reduced the ratio of active neurons and astrocytes (Fig. 8) to an extent similar to CBX and Cx43 
antibody (32.9 ± 2.7% of neurons and 16.2 ± 4.2% of astrocytes, p < 0.001 compared to control for both neurons 
and astrocytes). Also, similar to the Cx43 antibody (Fig. 7), the ratio of active cells slowly decreased over time, 
opposite to the increase observed in untreated animals (Fig. 5A).
All three investigated compounds, inhibiting intercellular Ca2+ spreading in astrocytes decreased the astro-
cytic and neuronal involvement in SWA, conclusively suggesting that astrocytes play a causal role in the genera-
tion and/or propagation of SWA.
Figure 6. The gap junction blocker carbenoxolone (CBX) reduces the number of astrocytes and neurons taking 
part in the slow wave-associated network activity. (A) Expression of GCaMP2 (green), labeling of astrocytes 
with SR101 (red). Both neurons (some marked by arrows) and astrocytes (some marked by arrowheads) 
express GCaMP2. Scale bars: 100 µm (B) Left: 10-sec segments of ∆F/F0 fluorescent intensity traces of all 
identified astrocytes (n = 18) and neurons (n = 11) in the imaged area in the absence of CBX at 38 min following 
anesthesia. Right: 10-sec segments of ∆F/F0 fluorescent intensity traces of all identified astrocytes (n = 17) 
and neurons (n = 6) in the imaged area in the presence of CBX at 80 min following anesthesia. Different cells 
were imaged at 38 and 80 min. (C) Representative LFP recordings low-pass filtered at 20 Hz at different stages 
shown in B. (D) Top: Ratio of V1 neurons (black) and astrocytes (red) in the field of view showing repetitive 
Ca2+ transients under ketamine/xylazine anesthesia before and after i.p. administration of 100 mg/kg CBX. 
Individual markers represent data from each 60-sec imaging sessions. Bottom: Average amplitude of local field 
potential (LFP) positive deflections in each 1-minute segment of the LFP recording in the rat primary visual 
cortex V1 before and after i.p. administration of 100 mg/kg CBX. All data were recorded from the V1 area of a 
P44 rat (n = 24 imaging session, 60 s each).
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Discussion
Despite the widely recognized relevance of cortical SWA, its cellular mechanism is currently far from being 
understood. The experiments described in this paper demonstrate, for the first time, that the astrocytic network 
does display extensive synchronized activity during in vivo SWA, simultaneously with the activation of the neu-
ronal network. Using a rat line stably expressing the genetically encoded calcium sensor protein GCaMP2 in 
astrocytes and interneurons, we showed that in the ketamine/xylazine anesthesia model of slow-wave sleep, large 
Figure 7. Specific blockade of the astrocytic gap junction subtype Cx43 inhibits synchronization in both 
astrocytes and neurons in vivo. (A) Expression of GCaMP2 (green), labeling of astrocytes with SR101 (red). 
Both neurons (some marked by arrows) and astrocytes (some marked by arrowheads) express GCaMP2. 
Scale bars: 100 µm (B) Left: 10-sec segments of ∆F/F0 fluorescent intensity traces of all identified astrocytes 
(n = 15) and neurons (n = 34) in the imaged area at 23 min following anesthesia. Right: 10-sec segments of ∆F/
F0 fluorescent intensity traces of all identified astrocytes (n = 15) and neurons (n = 34) in the imaged area at 
56 min following anesthesia. The same cells were imaged at 23 and 56 min. Cx43 antibody was applied 24 hours 
before the experiment. (C) The ratio of astrocytes (red) and neurons (black) showing repetitive, UP state-related 
Ca2+ transients in percentage of all astrocytes or neurons, respectively, in the field of views in the same P43 rat 
in the presence of Cx43 antibody (solid markers).Individual markers represent data from each 300-sec imaging 
sessions. Empty markers represent the ratio of astrocytes (red) and neurons (black) showing repetitive, UP 
state-related Ca2+ transients in the absence of Cx43 antibody. Note that large-scale synchronization is inhibited 
by the Cx43 antibody in both neurons and astrocytes. All data were recorded from the V1 area of a P43 rat 
(n = 15 imaging session, 300 s each).
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fractions of both cell types are concurrently activated during the UP states in the superficial layers of the primary 
visual cortex. Temporal parameters, such as frequency of the observed calcium transients were not significantly 
different in the two cell types. Cross-correlation analyses also did not show any time lag between the fluorescent 
traces, suggesting a functional link between their activities. In the spatial dimension, however, significant dif-
ferences were observed between the astrocytic and neuronal activity. Importantly, the ratio of active astrocytes 
was significantly higher than that of active neurons in the first 30 min of anesthesia, suggesting a principal role of 
astrocytes in the generation or spreading of SWA. After about 60 min virtually all neurons and astrocytes partic-
ipated in the synchronous oscillatory activity, followed by a steep decline in the spatial consistency of the astro-
cytic calcium signals, while the neuronal synchronization still involved all neurons. This difference may further 
strengthen the view that astrocytic activity during SWA is not a response to neuronal firing, rather an independ-
ent and potentially causal actor. Since a major route of astrocytic synchronization is mediated by gap junctions45, 
we addressed this potential role by applying the general gap junction inhibitor CBX and an inhibitory antibody 
specific to astrocytic Cx43 connexins. The purpose of these agents was to prevent physical coupling of astrocytes 
Figure 8. Specific reduction of the astrocytic Ca2+ transients by thapsigargin inhibits synchronization in both 
astrocytes and neurons in vivo. (A) Expression of GCaMP2 (green), labeling of astrocytes with SR101 (red). 
Both neurons (some marked by arrows) and astrocytes (some marked by arrowheads) express GCaMP2. Scale 
bars: 100 µm (B) Left: 10-sec segments of ∆F/F0 fluorescent intensity traces of all identified astrocytes (n = 8) 
and neurons (n = 37) in the imaged area at 20 min following anesthesia. Right: 10-sec segments of ∆F/F0 
fluorescent intensity traces of all identified astrocytes (n = 6) and neurons (n = 46) in the imaged area at 32 min 
following anesthesia. Different cells were imaged at 20 and 32 min. Thapsigargin was applied 30 min before the 
experiment. (C) The ratio of astrocytes (red) and neurons (black) showing repetitive, UP state-related Ca2+ 
transients in percentage of all astrocytes or neurons, respectively, in the field of view of the same P38 rat in the 
presence of thapsigargin (solid markers). Individual markers represent data from each 300-sec imaging sessions. 
Empty markers represent the ratio of astrocytes (red) and neurons (black) showing repetitive, UP state-related 
Ca2+ transients in the absence of thapsigargin. Note that large-scale synchronization is inhibited by thapsigargin 
in both neurons and astrocytes. All data were recorded from the V1 area of a P38 rat (n = 9 imaging session, 
300 s each).
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and to reduce their capacity for long-range synchronization. We demonstrated that both CBX and Cx43 antibody 
application significantly reduced the involvement of not only astrocytes, but also neurons in SWA, suggesting 
that astrocytes play a causal role in SWA. Furthermore, CBX also reduced the amplitude of LFP deflections, con-
firming that blockade of direct coupling between astrocytes significantly reduced the number of neurons taking 
part in SWA. Importantly, perturbation of long-range astrocytic synchronization by another mechanism, through 
the astrocyte-specific inhibition of intracellular Ca2+ transients by thapsigargin provoked the same reduction in 
SWA-related astrocytic and neuronal activity. The significant reduction of neuronal SWA following specific inhi-
bition of astrocytic network synchronization by two pathways makes causal role of astrocytes in SWA generation 
the most reasonable explanation of the results.
Both astrocytes and interneurons are powerful modulators of neuronal excitabil-
ity. Computational studies suggested various molecular and cellular mechanisms as generators of UP states in 
slow-wave sleep. According to these neurocentric explanations, the emergence of synchronous neuronal activity 
may be the consequence of the amplification of miniature synaptic potentials by intrinsically bursting neurons46 
or spontaneous activation of a small population of neurons47. The common property of these models is that the 
initial expansion of synchronous firing from a few cells to a smaller network requires the balancing of excitation 
by inhibitory currents. This feature makes GABAergic interneurons, that control the excitability of pyramidal 
cells at multiple subcellular regions48, key candidates for orchestrating neuronal activity. Indeed, GABAA receptor 
mediated synaptic currents have been shown to lie behind the emergence of gamma oscillations49. Recently, it 
was also demonstrated that GABAergic interneurons are specifically activated during sleep in the cortex of both 
human50 and rodents51, 52, further supporting their contribution to SWA generation.
Importantly, however, interneurons are not the only cell types that can provide synchronized inhibition 
over a large number of neurons. Astrocytes are also endowed to control the excitability of nearby neurons (both 
interneurons and pyramidal cells) and to spread information through their heavily interconnected network, 
thereby establishing neuronal synchronization on large spatial scales53. Many of the essential features of astro-
cytes and astrocytic networks, like bidirectional communication with neurons23, covering of up to millions of 
synapses54 and their extensive physical interconnection by gap junctions, position them as key players in a wide 
range of physiological functions from brain rhythm generation15, through memory formation55 up to behavior2.
Astrocytic network activation contributes to the build-up of neuronal synchronization. There 
is a consensus that DOWN states during SWA are commenced by the termination of an excitatory drive56, 57, 
rather than by the emergence of an active inhibition. This view is strongly supported by the fact that inhibitory 
interneurons are also inactive in the DOWN states. Astrocytes are able to exert long-lasting inhibitory control over 
neurons by increasing the ambient extracellular GABA concentration and by generating tonic inhibition8–10, 58, 59. 
Therefore, in principle, they may function in the opposite way, providing sustained inhibition during the DOWN 
states. This effect may have been easily overlooked in previous studies since astrocytes do not experience large 
membrane potential fluctuations, therefore they do not contribute to the widely studied electrophysiological 
signals to a significant extent.
In the present in vivo study, however, we observed that, just like neurons, astrocytes are active in the UP 
states. Thus, they may take part in the initiation rather than the termination of neuronal synchronization. A small 
number of pioneering in vitro, single-cell studies also support this finding. Electrophysiological double recording 
of neurons and astrocytes revealed that the two cell types display coherent activities during slow-wave oscilla-
tions in vitro53. Importantly, the same study also demonstrated that the beginning of neuronal DOWN states 
was preceded by glial hyperpolarization, suggesting causal relationship53. In another study, stimulation of single 
astrocytes was found to trigger neuronal UP states60. The latter study also revealed that disruption of astrocytic 
Ca2+ wave propagation by injection of a Ca2+ chelator into a single astrocyte inhibited both spontaneous and 
stimulated UP states. Chelation of calcium in a single astrocyte was also shown to inhibit long-term potentiation 
specifically in the domain of the chelator-loaded astrocyte61. The universality of this mechanism is further illus-
trated by the fact that astrocytic calcium chelation also produced neuronal network desynchronization in the 
hippocampus in vitro62.
Recently, an in vivo study by Poskanzer and Yuste63 described observations supporting in vitro results. In 
urethane-anesthetized mice, the authors described spontaneously alternating recurrent cortical states of syn-
chronized activity, representing a notable model, midway from in vitro preparations generating sparse local field 
potential activity in every 5.15 ± 0.27 min60 to physiological ~1 Hz SWA (present study). In their in vivo study, the 
authors showed that prior to the synchronized states occurring every 5.4 ± 0.37 min (0.003 Hz), astrocytic Ca2+ 
transients with a mean duration of 15.7 ± 0.83 s occurred, implying causality between the two events. Findings 
reported in the present study underlie this hypothesis by demonstrating that astrocytes actively contribute to the 
synchronization of neuronal networks not only in less complex in vitro preparations53, 60–62 and during sparsely 
occurring synchronized states in vivo63, but also during genuine SWA (~1 Hz), a complex, wide-scale, fundamen-
tal physiological phenomenon. Importantly, taking advantage of our high-speed two-photon acquisition system 
(30–156 Hz sampling rate), we were able to detect fast Ca2+ signals with duration of a few hundred millisec-
onds that were not resolved in the above study using 1–4 Hz sampling rate63. Unlike the slow Ca2+ transients 
that showed no apparent synchronization63, the fast Ca2+ signals revealed in our experiments were highly syn-
chronized both among astrocytes and co-synchronized to neurons. This might be indicative of the fact that the 
bidirectional communication at the neuron-glia interface operates faster than expected. However, despite the 
fundamental difference in the dynamics of the slow63 and fast (present study) Ca2+ transients, both signals were 
shown to contribute to the emergence of neuronal synchronization. The coupling of both slow and fast Ca2+ 
signalling to the neuronal activation may be indicative of the scale-free nature of the astrocytic Ca2+ dynamics64, 
featuring fractal organization of neural functions operating at time-scales with orders of magnitude disparity65. 
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Although model differences might also be accounted for the phenomena, universality of neocortical coupling of 
astrocytic and neuronal circuits may highlight a role for system adaptation.
Importantly, the significant impact of the number of active neighbouring astrocytes on the involvement of 
a given neuron in the SWA (Fig. 5C) strongly highlights the causal role the astrocytic network may play in the 
generation of neuronal synchronization. The importance of neighbouring astrocyte density may correspond 
to the domain-like control that astrocytes exert on neuronal excitability. In contrast to neurons that send and 
receive connections to and from long distances by their axons and dendritic trees, astrocytes occupy local, 
non-overlapping domains66. The efficacy of all synapses within a domain is controlled by a single astrocyte that 
can release both inhibitory (e.g. GABA, ATP) and excitatory (e.g Glu, d-serine) signalling molecules8, 9, 59, 61, 67–71. 
Since the dendritic tree of a neuron is covered by multiple astrocytes, increasing the number of neighbouring 
active astrocytes around a neuron should increase the strength of astrocytic control. A theoretical modelling 
study by Savtchenko and Rusakov72 previously showed that spatially clustered (i.e. domain-like) control over 
neuronal excitability is more efficient in generating and maintaining rhythmic activity than neuron-like spatially 
distributed inputs. Based on their modelling results the authors proposed that astrocytes are designed to pre-
serve network oscillation72. This hypothesis was reinforced by a recent modelling study showing that intercellular 
Ca2+ signalling potentially can introduce slow oscillation in neurons73. Our experimental data strongly supports 
this hypothesis by demonstrating that increasing astrocytic influence on neurons indeed drives them to join the 
oscillatory activity (Fig. 5C). In this context it is also important to note, that the ratio of astrocytes involved in the 
SWA was found to start decreasing right after virtually all neurons joined the simultaneous activity (Figs 4 and 5). 
This observation further supports the view that astrocytic activity corresponds to the generation or maintenance, 
rather than termination of SWA.
Therefore, combining the results of previous in vitro and in vivo experiments as well as theoretical studies 
with the present experimental in vivo findings, it is safe to conclude that the astrocytic network plays a role in the 
build-up phase of synchronous neuronal activity and that active contribution of astrocytes to the synchronization 
of the neuronal network is a viable hypothesis.
Causal role of astrocytes in SWA generation. It is a fundamental question what is the relationship in 
the observed concurrent activation of neurons and astrocytes. Whether astrocytic activity merely follows neu-
ronal firing or do astrocytes actively contribute to the generation or spreading of neuronal synchronized activity? 
Two considerable experimental limitations prevented us from directly targeting this issue. First, the activity of 
pyramidal cells, an important cell type in all kinds of cortical activity could not be monitored due to the lack of 
GCaMP2 expression in these cells. Although LFP recordings gave information about the activity of pyramidal 
cells as well, our tools were not amenable to record their cellular-level spatial activity patterns directly. Second, 
the first 10–15 min of anesthesia could not be recorded, since this time was required to position the anesthetized 
animal in the microscope and to set up electrophysiological and imaging apparatus. Therefore, to address the 
question of causality, we perturbed astrocytic synchronization beforehand and measured whether or not neuronal 
SWA is affected by this intervention. Astrocytic synchronization was targeted by blocking gap junctional commu-
nication or inhibiting intracellular Ca2+ transients.
Gap junctions are the major path through which astrocytes can be synchronized45. However, gap junctions 
are expressed not only on astrocytes, but also on interneurons74, 75. Unfortunately, no specific small molecule 
inhibitor of either the glial or neuronal form of the gap junction forming connexin hemichannels exists. Available 
specific mimetic peptides, like the astrocyte-specific Cx43 inhibitor Gap19 cross the blood-brain barrier (BBB) 
to a very small extent even when combined with TAT sequence36, therefore they cannot be applied systemically. 
The small molecule inhibitor CBX that cross the BBB, however, is not selective, thus it inhibits both neuronal and 
astrocytic gap junctions. Hence, we applied both approaches, the general gap junction inhibitor CBX i.p. and a 
specific inhibitor of astrocytic gap junctions, a Cx43 antibody locally.
Compared to the control SWA period, application of CBX significantly reduced the ratio of astrocytes and 
neurons displaying Ca2+ transients corresponding to UP states. In parallel, the LFP amplitude was also considera-
bly reduced, demonstrating that gap junctions do play a significant role in SWA generation or maintenance. Since 
activity of the non-imaged pyramidal cells is a major contributor to the LFP signal, the reduction in LFP ampli-
tude suggests that not only interneuronal, but also the pyramidal activity is affected by CBX application. Due 
to the non-specificity of CBX, however, we could not unambiguously conclude whether the observed changes 
are due to the blockade of the astrocytic or neuronal isoforms. Therefore, the astrocytic Cx43 isoform was spe-
cifically blocked by a Cx43 antibody that was previously successfully applied in vitro for specific astrocytic gap 
junction inhibition16, 39. However, since this antibody does not cross the BBB and the spatial extent of the affected 
area upon local pressure injection cannot be reliably controlled, the Cx43 antibody could not be applied during 
the experiment. Instead, astrocytic and neuronal activity measured in its presence was compared to activities 
obtained in the absence of the inhibitor. The significant reduction of neuronal SWA activity in the presence of the 
specific Cx43 antibody suggests that astrocytic gap junctions do contribute to SWA generation or spreading. This 
contribution is further supported by the in vitro observation that astrocytic connexin 43 hemichannel opening 
increases the amplitude of UP states and neuronal firing in rats76. To resolve whether the critical contribution of 
astrocytes is required for the SWA generation or spatial extension of the synchronized activity will require further 
studies targeting the wakefulness-sleep and sleep-wakefulness transitions.
Finally, the causal role of astrocytes in the generation or spreading of SWA is further strengthened by the 
fact that astrocyte-specific inhibition of intracellular Ca2+ transients by thapsigargin also significantly reduced 
the ratio of neurons involved in SWA. The observed effect in the presence of thapsigargin clearly excludes the 
possibility that astrocytic gap junction blockade achieves neuronal SWA reduction by a mechanism other than 
astrocytic Ca2+ signalling.
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Contribution of astrocytes to other types of neuronal synchronization. It has been demonstrated 
that specific inhibition of astrocytic vesicular release leads to significant reduction of gamma oscillations and 
consequently impairs recognition memory in mice77, further highlighting the role astrocytic networks play in 
higher cognitive functions. Contribution of astrocytic networks is also supported by recent computational stud-
ies that showed astrocytic tuning of hippocampal neuronal network activity in the delta frequency range15. The 
same study suggested the possibility of astrocytic background in the emergence of epileptic activity, which we 
previously confirmed by demonstrating that astrocytic and neuronal networks show concurrent, synchronized 
activity and that disruption of astrocytic synchronization by CBX or Cx43 antibody prevents the generation of 
seizure-like events16. These data indicate that astrocytic activity is not merely coupled to neuronal firing pattern 
during brain oscillations, but it may play a causal role in triggering rhythmic neuronal activity. Our transgenic rat 
line stably expressing GCaMP2 in both astrocytes and neurons may serve as a model to study such higher cogni-
tive functions in rat that clearly outperforms the widely used mouse models in cognitive tasks78.
In conclusion, multiple lines of in vitro experimental data suggest that astrocytic networks are able to funda-
mentally control neuronal network activity and significantly contribute to the generation or spreading of brain 
oscillations. In line with these in vitro findings, our in vivo data demonstrate, for the first time, that astrocytic 
networks display coherent activity during SWA and this activity is proposed to play a causal role in SWA genera-
tion. We envisage that the in vivo identification of the astrocytic network as a key player in brain oscillations will 
deepen our understanding of these fundamental features of the brain function.
Methods
Animals. All animal procedures were performed according to standard ethical guidelines and approved by 
the local Animal Care Committee and the Government Office for Pest County (reference numbers PEI/001/3671-
4/2015 and 22.1/2727/3/2011). The transgenic rat strain stably expressing the CAG-GCaMP2 transgene was 
established earlier using the Sleeping Beauty transposon based gene delivery technology21. Additionally, two other 
homozygous rat strains were established with the same transposon technology: one expressing the red fluorescent 
RGECO calcium indicator under the regulation of the astrocyte specific GFAP promoter; the other strain con-
taining both the CAG-GCaMP2 and the rGFAP-RGECO transgenes in a homozygous (one haploid copy) form 
was established by the careful selection of the progenies from crossing the two original homozygous transgenic 
strains. In vivo experiments were performed on 4–8 week old transgenic male and female Wistar rats that were 
housed in a 12 hour light/dark cycle. All drugs were obtained from Sigma-Aldrich unless stated otherwise.
Slice culture. Since expression of GCaMP2 was largely reduced in acute slice preparations21 we used organo-
typic hippocampal slice cultures prepared according to the method of Kovács et al.79, with minor modifications. 
Briefly, 380 μm thick hippocampal slices were cut from 6-day-old Wistar rats using a McIlwain tissue chopper, 
and separated in ice-cold Gey’s balanced salt solution (GBSS) composed of (mM): 33 glucose, 2 CaCl2, 1.03 
MgCl2, 0.28 MgSO4, 0.22 KH2PO4, 27.02 NaHCO3, 120 NaCl, 0.84 Na2HPO4, 5 KCl, 10 HEPES, pH 7.2. The slices 
were placed on a culture plate insert (MilliCell-CM, Merck Millipore, Budapest, Hungary) and the inserts were 
transferred to a 6-well culture plate. Each well contained 1 ml of culture medium consisting of 50% Opti-MEM® 
I Reduced Serum Medium (Life Technologies, Budapest, Hungary), 25% HBSS, 25% horse serum, D-glucose 
(0.25 g/ml) and gentamicin (0.1 mg/ml). The organotypic cultures were maintained in a humidified incubator 
bubbled with a 5% CO2/95% O2 atmosphere at 37 °C for 3 days. On day 4, culture medium was replaced with 
another formulation and used afterwards (76% Neurobasal®-A Medium, minus phenol red (Life Technologies), 
1% GlutaMAX® Supplement, 2% B-27® Supplement, serum free, 1% D-glucose, 20% horse serum supplemented 
with (mM, final concentration): 0.1 D,L-α-Tocopherol, 0.5 ascorbic acid, 0.025 β-mercapto-ethanol; 0.1 mg/ml 
gentamicin). Culture medium was changed twice a week. Cultures were used for analyses within 3 weeks.
Immunohistochemistry. GAD67/GCaMP2 and GFAP/GCaMP2 colocalization studies were performed 
using a slightly modified protocol of Weiswald et al.80. Briefly, organotypic cultures were fixed in 4% paraform-
aldehyde +1% Triton X-100 for 3 h at 4 °C. Slices were washed and then further fixed sequentially in 50%, 90% 
and 50% methanol for 5 min at −20 °C. Cultures were washed in PBS, blocked with 1% bovine serum albumin 
+5% goat serum +0.1% Triton X-100 for 1 h at 4 °C. Rabbit anti-GFP (1:500, ab290, Abcam), mouse anti-GFAP 
(1:200, sc-33673, Santa Cruz) and mouse anti-GAD67 (1:1000, MAB5406, Merck Millipore) were dissolved in the 
blocking solution and the slices were incubated for 2 h at room temperature on a rocker shaker. After incubation 
in primary antibodies, the sections were washed, and incubated in goat anti-rabbit IgG Alexa Fluor 488 and goat 
anti-mouse IgG Alexa Fluor 546 secondary antibodies (1:200; Life Technologies) for 4 h at room temperature. 
Finally, the nuclei were stained with 2 µM Hoechst 33342 (10 min, RT) and the slices were covered with ProLong® 
Gold (Life Technologies).
To investigate NeuN/GCaMP2 and Iba1/GCaMP2 colocalization, organotypic cultures were fixed in 4% par-
aformaldehyde, washed, and pretreated with 3% hydrogen peroxide for 10 min followed by 1% bovine serum 
albumin in PB containing 0.5% Triton X-100 for 30 min at room temperature. Then, the cultures were placed in 
goat anti-GFP (1:1000, ab5450, Abcam) for 24 h at room temperature. After incubation in primary antiserum, 
the sections were washed and incubated in biotinylated donkey anti-goat secondary antibody (1:1000; Jackson 
ImmunoResearch, West Grove, PA) for 1 h followed by washes and incubation in avidin-biotin-horseradish per-
oxidase complex (1:500; Vector Laboratories) for 1 h. Subsequently, sections were treated with FITC-tyramide 
(1:8000) and H2O2 in Tris hydrochloride buffer (0.1 M, pH = 8.0) for 6 min. Then, mouse anti-NeuN as a marker 
of neuronal nuclei (1:500; Millipore, Billerica, MA, cat. number: MAB377) or rabbit anti-ionized calcium-binding 
adapter molecule 1 (Iba1) as a marker of microglial cells (1:1000; Wako, cat. number: 019–197419) was applied 
at room temperature overnight. Sections were then incubated in donkey Alexa Fluor 594 anti-mouse secondary 
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antibody (Life Technologies, Grand Island, NY) for 2 h. Finally, the sections were mounted, dehydrated and cov-
erslipped with Cytoseal 60 (Stephens Scientific, Riverdale, NJ).
In vitro imaging. Slice cultures were transferred to the recording chamber mounted on an upright micro-
scope (Olympus BX61WI) equipped with a FluoView300 confocal laser-scanning system (Olympus, Tokyo, 
Japan) or on a two-photon microscope (Femto2D, Femtonics, Hungary) using a 40× water immersion objective 
(N.A. 0.80). Slices were superfused with oxygenated (95% O2, 5% CO2) artificial cerebrospinal fluid (ACSF) (5 ml/
min, 30 °C), containing (in mM): 129 NaCl; 1.23 NaH2PO4; 10 glucose; 1.6 CaCl2; 3 KCl; 21 NaHCO3; 1.8 mM 
MgSO4 (pH 7.4). In confocal microscopy GCaMP2 fluorescence was excited at 488 nm and emission was detected 
between 510–530 nm. In two-photon microscopy GCaMP2 was excited at 900 nm with a MaiTai femtosecond 
laser source (Spectra Physics, Santa Clara, CA, USA) and the emitted fluorescence was monitored at 475–575 nm.
In vitro electrophysiological recordings. Whole-cell recordings in organotypic slices were made at 
∼32 °C from cells identified under continuous GCaMP2 imaging. Borosilicate glass capillaries had open-tip 
resistances between 4–6 MΩ. For current clamp recordings the intracellular solution contained (in mM): 135 
K-gluconate, 10 HEPES, 10 Na-phosphocreatine, 4 KCl, 4 Mg-ATP, 0.3 Na-GTP, pH 7.2 (adjusted with KOH). 
Signals were recorded with Multiclamp 700A amplifiers (Axon Instruments, Foster City, CA, USA), sampled at 
10 kHz (Digidata 1320 A, Axon Instruments), and stored on a personal computer for subsequent analysis. Liquid 
junction potential of −15.7 mV was calculated by the Clampex software and used to determine cell membrane 
potentials. Action potentials were evoked by somatic current injection (0.5–1.0 nA, 2 ms). Glutamate (100 μM), 
ATP (1 mM) and ionomycin (10 μM) were applied in perfusion bath.
Cranial window implantation. Rats were anesthetized with ketamine-xylazine (ketamine 100 mg/kg, 
xylazine 10 mg/kg) or fentanyl-medetomidine-midazolam mixtures (fentanyl 0.05 mg/kg, medetomidine 0.5 mg/
kg, midazolam 5.0 mg/kg). Depth of anesthesia was assessed by monitoring pinch withdrawal and eyelid reflex. 
Opticorn-A ophthalmic ointment was applied to the eyes to prevent cornea dehydration during surgery.
A 4–5 mm-diameter craniotomy was made above the primary visual cortex in the left hemisphere under a 
dissection microscope by using stainless steel drilling bits. After opening the skull, the cortical surface was kept 
moist with Ringer’s buffer. Dura mater was carefully removed, and 2 µl SR101 (200 µM) was pipetted onto the 
brain surface and left for 5 min to stain astrocytes81, 82. The exposed cortex was sealed with a stack of 4 mm diam-
eter glass coverslips glued together using Norland Optic Adhesive (Thorlabs, Newton, NJ, USA). In some experi-
ments where an extracellular recording electrode was inserted into the craniotomy, part of the hole was left open 
and was covered only with low-melting point agarose. The rat was transferred into the imaging set-up, placed on 
a warming plate (37 °C), and head-fixed in a stereotaxic frame (David Kopf Instruments, Tujunga, CA, USA). 
Alternatively, a custom-made metal bar was attached to the skull with C&B-Metabond® adhesive cement (Parkell, 
Edgewood, NY, USA) to allow for subsequent head fixation during calcium imaging.
In vivo imaging and electrophysiological recording. GCaMP2 expressing neurons in 100–300 µm 
depth (corresponding to layer 2) of the V1 primary visual cortex area were imaged using a two-photon micro-
scope (Femto2D-Dual, Galvo-Resonant, Femtonics, Budapest, Hungary) equipped with a 16x water immersion 
objective excited by 875 nm laser line (Chameleon, Coherent, Santa Clara, CA, USA). GCaMP2 fluorescence was 
detected at 490–550 nm in either line-scan (32–156 Hz sampling rate) or full-frame (30–45 Hz sampling rate) 
mode. In experiments not performed on the day of the surgery, SR101 was reapplied intravenously to the tail vein 
in 10 mM (100 µl) at least 1 hour before the imaging81. SR101 has been proven not to label neurons81. Although 
oligodendrocyte labelling may occur after longer incubation81, oligodendrocytes are far less abundant83 in the 
superficial layers of the cortex compared to astrocytes. Therefore, it is safe to identify SR101 positive cells as 
astrocytes. SR101 positive astroglia were detected at 570–640 nm. The length of imaging recording sessions was 
60 or 300 s, sessions were repeated 6–24 times during the anesthesia. In many cases, imaging sessions were made 
at different regions within the V1 area. Possible respiratory coupling with the fluorescent signal was controlled 
by parallel recording of breathing rate with a thermocouple (5TC-TT-J-36-36, Omega Engineering, CT, USA) 
inserted into the animals’ nostril. Local field potential (LFP) recordings were made in the same cortical layer with 
glass capillaries (3–6 MΩ) filled with Ringer’s buffer, inserted underneath the coverslip under visual guidance.
Drugs for perturbing astrocytic Ca2+ signalling were administered by two different methods. CBX was 
injected i.p. in 100 mg/kg concentration during SWA imaging. This experimental design allowed us to directly 
compare imaging and LFP data obtained in the absence and presence of the inhibitor. In contrast to CBX, the 
Cx43 antibody and thapsigargin do not cross the blodd-brain barrier, therefore these agents were applied directly 
onto the cortical surface after removal of the dura. Cx43 antibody (0.75 mg/ml, 10 μl) was applied 24 h before 
the experiment to allow diffusion into the tissue. The ability of the antibody to penetrate into the brain at this 
time scale was confirmed by applying an Alexa-488 labelled secondary antibody in the same concentration in 
a wild-type, age-matched rat. 24 h after the application Alexa-488 fluorescence was clearly detectable even at 
800 μm depth. Thapsigargin (0.5 mM, 10 μl) was also applied onto the brain surface 30 min before the experiment. 
Under these conditions thapsigargin was demonstrated to specifically inhibit astrocytic Ca2+ signalling44.
Data evaluation. Cells on full frame GCaMP2 fluorescence images were identified by semi-automatic 
Matlab scripts under manual supervision. The identified regions of interests (ROIs) contained the soma of the 
cells slightly expanded by 2–3 pixels in all directions to reduce the noise in fluorescence intensity. The identified 
ROIs (in full-frame scan mode) or the cells around the line scan segments (in line-scan mode) were visually 
validated and the cell type (neuron or astrocyte) was determined based on the absence or presence of SR101 
labelling in the same ROI. Average intensity in the identified ROIs was then calculated followed by subtraction of 
and dividing by the average intensity of ROIs in the first 10 samples. Fluorescence peaks on the detrended ΔF/F0 
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traces were identified using 2*SD as amplitude threshold and 0.1 as slope-to-peak threshold. Detection thresh-
olds were selected after manually revising calculated ΔF/F0 traces from 2 animals.
Spatial consistency of neuronal and astrocytic activities was assessed by calculating the number of manually 
validated cells showing recurrent Ca2+ transients in the 0.5–2 Hz frequency range during the 60–300 s recording 
sessions and dividing this value by the number of validated neurons or astrocytes within the same field of view.
The effect of the number of surrounding active cells on the activity of the enclosed neurons or astrocytes 
was calculated by determining the distance between all cell pairs in 5 different animals (N = 263478 cell pairs). 
Data from different experimental sessions on the same animals were pooled. Percentage of the enclosed cells’ 
involvement in the SWA was determined by counting the number of astrocytes or neurons showing SWA-related 
rhythmic activity and having 0, >1, >2, >3, >4 adjacent astrocytes or neurons within 100 µm. This count was 
divided by the number of all astrocytes or neurons having 0, >1, >2, >3, >4 adjacent astrocytes or neurons 
within 100 µm.
For spectral analysis LFP recordings were bandpass filtered using Bessel filters. Wavelet analysis was per-
formed using complex Morlet wavelets.
Unless stated otherwise, data are expressed as means ± S.E.M. and were analyzed using one-way analysis of 
variances with Bonferroni post hoc tests (OriginPro 8.0). A value of P < 0.05 was considered significant.
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